⌘K

Home/Filings/4/0001252491-13-000001

4//SEC Filing

OXYGEN BIOTHERAPEUTICS, INC. 4

Accession 0001252491-13-000001

$TENXCIK 0000034956operating

View on SEC.gov Company Profile

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 1:44 PM ET

Size

8.1 KB

Accession

0001252491-13-000001

Insider Transaction Report

Form 4

Period: 2013-07-23

OXYGEN BIOTHERAPEUTICS, INC.oxbt

DiTonno Anthony A

Director

Transactions

Purchase
Series C 8% Convertible Preferred Stock
2013-07-23+5→ 5 total
Exercise: $1.95From: 2013-07-23→ common stock (2,564 underlying)
Purchase
Common Stock Warrants (right to buy)
2013-07-23+2,565→ 2,565 total
Exercise: $2.60From: 2013-07-23Exp: 2019-07-23→ common stock (2,565 underlying)

Footnotes (2)

[F1]The Series C 8% Convertible Preferred Stock has no expiration date.
[F2]The reported securities are included within 25 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (1) a share of Series C 8% Convertible Preferred Stock which is convertible into approximately 512.82 shares of our common stock, and (2) one warrant exercisable for 512.82 shares of common stock at an exercise price of $2.60 per share.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

OXYGEN BIOTHERAPEUTICS, INC.

CIK 0000034956

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000034956

Filing Metadata

Form type: 4
Filed: Jul 25, 8:00 PM ET
Accepted: Jul 26, 1:44 PM ET
Size: 8.1 KB

View on SEC.gov